Literature DB >> 31622515

An engineered ultra-high affinity Fab-Protein G pair enables a modular antibody platform with multifunctional capability.

Tomasz Slezak1, Lucas J Bailey1, Mateusz Jaskolowski1,2, Dominik A Nahotko1, Ekaterina V Filippova1, Elena K Davydova1, Anthony A Kossiakoff1.   

Abstract

Engineered recombinant antibody-based reagents are rapidly supplanting traditionally derived antibodies in many cell biological applications. A particularly powerful aspect of these engineered reagents is that other modules having myriad functions can be attached to them either chemically or through molecular fusions. However, these processes can be cumbersome and do not lend themselves to high throughput applications. Consequently, we have endeavored to develop a platform that can introduce multiple functionalities into a class of Fab-based affinity reagents in a "plug and play" fashion. This platform exploits the ultra-tight binding interaction between affinity matured variants of a Fab scaffold (FabS ) and a domain of an immunoglobulin binding protein, protein G (GA1). GA1 is easily genetically manipulatable facilitating the ability to link these modules together like beads on a string with adjustable spacing to produce multivalent and bi-specific entities. GA1 can also be fused to other proteins or be chemically modified to engage other types of functional components. To demonstrate the utility for the Fab-GA1 platform, we applied it to a detection proximity assay based on the β-lactamase (BL) split enzyme system. We also show the bi-specific capabilities of the module by using it in context of a Bi-specific T-cell engager (BiTE), which is a therapeutic assemblage that induces cell killing by crosslinking T-cells to cancer cells. We show that GA1-Fab modules are easily engineered into potent cell-killing BiTE-like assemblages and have the advantage of interchanging Fabs directed against different cell surface cancer-related targets in a plug and play fashion.
© 2019 The Protein Society.

Entities:  

Keywords:  Phage display; Protein G; affinity maturation; bi-specific T-cell engagers; engineered Fab; proximity assay; split enzyme

Mesh:

Substances:

Year:  2019        PMID: 31622515      PMCID: PMC6933859          DOI: 10.1002/pro.3751

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  58 in total

1.  Beta-lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein protein interactions.

Authors:  André Galarneau; Martin Primeau; Louis-Eric Trudeau; Stephen W Michnick
Journal:  Nat Biotechnol       Date:  2002-06       Impact factor: 54.908

2.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

3.  Two-state selection of conformation-specific antibodies.

Authors:  Junjun Gao; Sachdev S Sidhu; James A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-10       Impact factor: 11.205

4.  Rapid purification of human peripheral blood monocytes by centrifugation through Ficoll-Hypaque and Sepracell-MN.

Authors:  M C Vissers; S A Jester; J C Fantone
Journal:  J Immunol Methods       Date:  1988-06-13       Impact factor: 2.303

5.  Mechanism of T lymphocyte activation by OKT3 antibodies. A general model for T cell induction.

Authors:  U Landegren; J Andersson; H Wigzell
Journal:  Eur J Immunol       Date:  1984-04       Impact factor: 5.532

6.  T cells from patients successfully treated with OKT3 do not react with the T-cell receptor antibody.

Authors:  H M Gebel; L K Lebeck; S C Jensik; K Webster; R A Bray
Journal:  Hum Immunol       Date:  1989-10       Impact factor: 2.850

7.  Integration, scaling, space-group assignment and post-refinement.

Authors:  Wolfgang Kabsch
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

8.  Synthetic antibodies for specific recognition and crystallization of structured RNA.

Authors:  Jing-Dong Ye; Valentina Tereshko; John K Frederiksen; Akiko Koide; Frederic A Fellouse; Sachdev S Sidhu; Shohei Koide; Anthony A Kossiakoff; Joseph A Piccirilli
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-27       Impact factor: 11.205

9.  How good are my data and what is the resolution?

Authors:  Philip R Evans; Garib N Murshudov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-06-13

10.  Beyond natural antibodies: the power of in vitro display technologies.

Authors:  Andrew R M Bradbury; Sachdev Sidhu; Stefan Dübel; John McCafferty
Journal:  Nat Biotechnol       Date:  2011-03       Impact factor: 54.908

View more
  3 in total

1.  An engineered ultra-high affinity Fab-Protein G pair enables a modular antibody platform with multifunctional capability.

Authors:  Tomasz Slezak; Lucas J Bailey; Mateusz Jaskolowski; Dominik A Nahotko; Ekaterina V Filippova; Elena K Davydova; Anthony A Kossiakoff
Journal:  Protein Sci       Date:  2019-11-01       Impact factor: 6.725

Review 2.  Protein Engineering: Advances in Phage Display for Basic Science and Medical Research.

Authors:  Elena K Davydova
Journal:  Biochemistry (Mosc)       Date:  2022-01       Impact factor: 2.487

3.  Engineering of a synthetic antibody fragment for structural and functional studies of K+ channels.

Authors:  Ahmed Rohaim; Tomasz Slezak; Young Hoon Koh; Lydia Blachowicz; Anthony A Kossiakoff; Benoît Roux
Journal:  J Gen Physiol       Date:  2022-03-02       Impact factor: 4.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.